Authors: Srinivas, VS Cannon, CP Gibson, CM Antman, EM Greenberg, MA Tanasijevic, MJ Murphy, S de Lemos, JA Sokol, S Braunwald, E Mueller, HS

Citation: Vs. Srinivas et al., Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: A thrombolysis in myocardial infarction 10B substudy, AM HEART J, 142(1), 2001, pp. 29-36

Authors: Kizer, JR Cannon, CP McCabe, CH Mueller, HS Schweiger, MJ Davis, VG Perritt, R Antman, EM

Citation: Jr. Kizer et al., Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience, AM HEART J, 137(1), 1999, pp. 79-92

Authors: Cannon, CP Gibson, CM McCabe, CH Adgey, AAJ Schweiger, MJ Sequeira, RF Grollier, G Giugliano, RP Frey, M Mueller, HS Steingart, RM Weaver, WD Van de Werf, F Braunwald, E

Citation: Cp. Cannon et al., TNK tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction - Results of the TIMI 10B trial, CIRCULATION, 98(25), 1998, pp. 2805-2814